The Patent Finder

Terms ending in 2037

Hemanext Inc.

Every in-force patent on Hemanext Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,583,192Anaerobic Blood Storage and Pathogen Inactivation Method
In force
 · Low confidence
Hemanext Inc.In forceLow confidence
US 11,147,876Anaerobic Blood Storage and Pathogen Inactivation Method
In force
 · High confidence
Hemanext Inc.In forceHigh confidence
US 11,911,471Anaerobic Blood Storage and Pathogen Inactivation Method
In force
 · High confidence
Hemanext Inc.In forceHigh confidence
US 12,364,760Anaerobic Blood Storage and Pathogen Inactivation Method
In force
 · Medium confidence
Hemanext Inc.In forceMedium confidence
US 11,090,331Methods and Treatment for Reducing the Risk of an Inflammatory Response
In force
 · Medium confidence
Hemanext Inc.In forceMedium confidence
US D961,765Blood Storage Bag
In force
 · High confidence
Hemanext Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited